TableĀ 2

Study characteristics

StudyStudy characteristicsPatients' characteristics
CountryDesignNumber of patients at recruitmentNumber of patients at final FUNumber of revisions/THAMean age (years)Gender (% female)
Dippmann et al29DenmarkCase series928753863
Fabricant et al30USACase series212101843
Frank et al31USACohort study646043363
Gicquel et al32FranceCase series565173163
Horisberger et al25SwitzerlandCase series887994132
Javed et al33UKCase series403376535
Krych et al34USARCT3636039100
Larson et al26USACohort study969063040
Larson et al35USACase series22022003152
Lerch et al36GermanyCase series40400390
Malviya et al37UKCase series122122NR3539
Martinez et al38SpainCase series41410330
Nielsen et al39DenmarkCase series1178853759
Palmer et al40USACase series194173124051
Park et al41KoreaCase series19719664551
Philippon et al42USACase series122102104155
Philippon et al43USACase series28262270
Philippon et al44USACase series153122315753
Polat et al45TurkeyCase series424113540
Polesello et al46BrazilCase series272433512
Redmond et al28USACohort study174158163363
Singh et al47AustraliaCase series2424NR220
Skendzel et al27USACase series5593141173738
Stahelin et al48SwitzerlandCase series222204232
Thomee et al49SwedenCase series50236003733
Zingg et al50SwitzerlandCase series232302822
  • FU, follow-up; NR, not reported; THA, total hip arthroplasty.